—
Meyer Burger: Wants to build a 400 MW production facility in the US state of Arizona. Could be expanded up to 1.5 GW.
Evolva: Receives an additional CHF 12 million from Nice & Green investment company. Funding requirements covered by the end of 2023.
Calida: Might part with the Millet Mountain Group outdoor business. ZKB estimates the potential proceeds at CHF 65 to 75 million. However, this remains for MARKET WEIGHTS.
Swiss credit: Accuses Japanese SoftBank due to total loss of $ 440 million on investment in US company.
Julius Bär: CHF 450 million share buyback program completed. Will the Zürcher Bank follow up with a follow-up program in a few weeks?
Novartis: Chairman of the company “Vas” Narasimhan’s chair wobbles, as reported by the NZZ on Sunday.
Roche: US FDA approves new Covid-19 rapid test for use at home.
Value: Research Partners throw in the towel. Go to HOLD (Buy) up to 150 (220) Fr. In the future, more restrained commuter behavior. Corporate strategy should only slowly bear fruit.
To the Rose: World’s largest asset manager Blackrock separates from stocks. Lately holds less than 3pc.
Derivatives: Quite a lull.
–
